Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

A novel second-generation platinum derivative and evaluation of its anti-cancer potential by Habibe Yilmaz (4865200)

“…In this study, cis-4-hydroxyphenylplatinum (II) diamine was synthesized with a yield of 62%. The MTT assay on A549-Luc and SKOV3-Luc cell lines resulted in IC50 values of 17.82 and 7.81 μM, respectively. …”

Supplementary Material for: Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study by Inês M. (5678270)

“…<b><i>Results:</i></b> Over 2010–2016 period, mean incidence rates was 0.87/100,000 (95% CI 0.68–1.10) corresponding to 71 new patients yearly, that has decreased 31% in the last 7 years. The proportion of late-onset cases (age ≥50 years) among incident cases was 28.7%. …”

Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity by Takafumi Yotsumoto (4994390)

“…Furthermore, we searched for the biomarker related to the bone and cartilage toxicity using rats treated with ASB20123 at doses of 0.005, 0.05, 0.5, and 5.0 mg/kg/day for 4 weeks. …”

The effect of normobaric oxygen in patients with acute stroke: a systematic review and meta-analysis by Jiayue Ding (4689559)

“…Compared to controls, there was a minor trend toward NBO benefits in short-term prognostic indices, as indicated by decreased ΔNIHSS at our defined time points. …”

Exogenous <i>miR-146a</i> expression enhances OSCC oncogenicity. by Pei-Shi Hung (489732)

Table 1_Muscle quality index and hyperuricemia: adipose tissue as a mediator.docx by Ya Shao (16975896)

“…Each one-unit increment in MQI corresponded to a 50% decrease in the odds of hyperuricemia (OR: 0.50, 95% CI: 0.43–0.57). …”

Data_Sheet_3_Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.PDF by Katalin Gombos (10033505)

Data_Sheet_2_Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.PDF by Katalin Gombos (10033505)

Data_Sheet_1_Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.PDF by Katalin Gombos (10033505)

Data_Sheet_4_Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.PDF by Katalin Gombos (10033505)

Image_1_Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study.pdf by Qingran Yan (637573)

“…The CRR rate was 42.3% (11/26) at month 6. With a median follow-up of 52 weeks (range: 23-116 weeks), the CRR rate at the last visit was 50% (13/26) and 73.1% (19/26) of patients had UPCR decrease of over 50%. …”

Granulocyte Colony-Stimulating Factor Reduces Fibrosis in a Mouse Model of Chronic Pancreatitis by Wey-Ran Lin (615284)

“…</p><p>Methods</p><p>CP was induced in C57Bl/6J mice by consecutive cerulein injection (50 µg/kg/day, 2 days a week) for 6 weeks. Mice were then treated with G-CSF (200 µg/kg/day, 5 day a week) or normal saline for 1 week, and sacrificed at week 7 or week 9 after first cerulein injection. …”

Image_8_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_7_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_10_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_15_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_13_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_11_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”

Image_14_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

“…</p>Methods<p>We evaluated IgM, IgA, and IgG antibodies directed to the nucleocapsid (NP), IgA and IgG to the Spike protein and to the receptor-binding domain (RBD), and the presence of neutralizing antibodies (nAb), in a cohort of unvaccinated SARS-CoV-2 infected individuals, in the first 30 days of post-symptom onset (PSO) (T1).…”